Akimov A, Cherniavskyi V. Comparative effects of liraglutide and dapagliflozin on lipid profile and cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: a 6-month randomized study. USMYJ [Internet]. 2025Dec.22 [cited 2026Mar.21];158(4):17-6. Available from: https://mmj.nmuofficial.com/index.php/journal/article/view/593